Search news archive


Info










Search 

Today's news

Eli Lilly reports 'strong results'
Eli Lilly says it has seen a strong financial performance in the second quarter of this year.The drugs giant reported a net income of $958.8 million...
Bayer and Onyx hail 'landmark' liver cancer data
Bayer Healthcare and Onyx Pharmaceuticals have greeted "landmark" data from a study looking into the effects of their drug Nexavar in liver cancer.The...
Sanofi diabetes drug gets European approval
Apidra, the diabetes drug from Sanofi-aventis, has been granted approval by the European commission for use in children and adolescents.The company says the...
Shire announces senior appointment
Shire has announced the appointment of Dr Jeffrey Jonas to the post of senior vice-president of Research & Development (R&D) for its speciality...
Teva in $360m Bentley acquisition
Teva has revealed it has completed the acquisition of Bentley Pharmaceuticals for approximately $360 million (£180.4 million).Following the agreement,...

  Events calendar

HAYS Plc releases a Trading Statement for Q4  in anticipation
of the 2008 full year report.

For more info. visit HAYS Plc

 

Hays Pharma will be at the PhUSE conference at the Midland hotel in Manchester, UK, 12-15 October 2008

•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••

Hays Pharma is exhibiting at the BARQA 2nd Global Conference at the Edinburg int'l Conference centre, 29-31 Oct 2008